Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2019 inter alia to consider and approve We hereby inform you that pursuant to Regulation 29 of the Securities and Exchange Board of lndia (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of the Company is scheduled to be held on Thursday May 16 2019 to inter alia consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and the year ended March 31 2019 and recommendation of dividend if any amongst other matters.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
